Martha Pritchett Mims, M.D., Ph.D.

Professor

(713) 798-7535

Email

mmims@bcm.edu

Positions

Professor: Medicine
Hematology & Oncology
Baylor College of Medicine
Houston, TX, US

Associate Director of Clinical Research: Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Dan L Duncan Professorship: Baylor College of Medicine

Addresses

Alkek Building for Biomedical Research (Office): Room: ABBR-R405
Houston, TX, 77030
United States

Baylor College of Medicine Medical Center McNair Campus (Clinic): Dan L Duncan Comprehensive Cancer Center
7200 Cambridge St, 7B
Houston, TX, 77030
United States
Phone: (713) 798-3750

Education

Fellowship at Baylor College of Medicine: 06/2004 - Houston, TX, United States; Hematology and Oncology

Residency at Baylor College Of Medicine: 06/2001 - Houston, TX, United States; Internal Medicine

Internship at Baylor College of Medicine: 06/1999 - Houston, TX, United States; Internal Medicine

MD from Baylor College of Medicine: 05/1988 - Houston, TX, United States

PhD from Rice University: 01/1983 - Houston, TX, United States; Biochemistry

Post-Doctoral Fellowship at Baylor College of Medicine: 11/1987 - Houston, United States; Atherosclerosis

Certifications

Medical Oncology: American Board of Internal Medicine

Hematology: American Board of Internal Medicine

Internal Medicine: American Board of Internal Medicine

Professional Interests

Dr. Martha Mims treats patients with hematologic malignancies and solid tumors.

Websites

VIICTR Publications List

Section of Hematology and Oncology

Selected Publications

Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, Miles BJ, Wheeler TM, Harper JW, Tsai MJ, Ittmann MM, Kadmon D. " Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. " Clin. Cancer Res.. 2008 Nov 15; 14 (22) : 7511-8.
Pubmed PMID: 19010869.
Savoldo B, Ramos CA, Liu E, Mims MP, Keating MJ, Carrum G, Kamble RT, Bollard CM, Gee AP, Mei Z, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Dotti G. " CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. " J. Clin. Invest.. 2011 May 2; 121 (5) : 1822-6.
Pubmed PMID: 21540550.
Sanchez C, Chan R, Bajgain P, Rambally S, Palapattu G, Mims M, Rooney CM, Leen AM, Brenner MK, Vera JF. " Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer. " Prostate Cancer Prostatic Dis.. 2013 Jun ; 16 (2) : 123-31.
Pubmed PMID: 23295316.
Okur FV, Yvon E, Biagi E, Dotti G, Carrum G, Heslop H, Mims MP, Fratantoni JC, Peshwa MV, Li L, Brenner MK. " Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia. " Cytotherapy. 2011 Oct ; 13 (9) : 1128-39.
Pubmed PMID: 21745159.
Quintarelli C, Dotti G, De Angelis B, Hoyos V, Mims M, Luciano L, Heslop HE, Rooney CM, Pane F, Savoldo B. " Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. " Blood. 2008 Sep 1; 112 (5) : 1876-85.
Pubmed PMID: 18591381.
Mims MP, Prchal JT. " Divalent metal transporter 1. " Hematology. 2005 Aug ; 10 (4) : 339-45.
Pubmed PMID: 16085548.
Pospisilova D, Mims MP, Nemeth E, Ganz T, Prchal JT. " DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis. " Blood. 2006 Jul 1; 108 (1) : 404-5.
Pubmed PMID: 16790587.
Castro P, Creighton CJ, Ozen M, Berel D, Mims MP, Ittmann M. " Genomic profiling of prostate cancers from African American men. " Neoplasia. 2009 Mar ; 11 (3) : 305-12.
Pubmed PMID: 19242612.
Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D. " GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy. " Clin. Cancer Res.. 2011 Nov 15; 17 (22) : 7174-82.
Pubmed PMID: 21933889.
Quintarelli C, Dotti G, Hasan ST, De Angelis B, Hoyos V, Errichiello S, Mims M, Luciano L, Shafer J, Leen AM, Heslop HE, Rooney CM, Pane F, Brenner MK, Savoldo B. " High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells. " Blood. 2011 Mar 24; 117 (12) : 3353-62.
Pubmed PMID: 21278353.
Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, Ponka P, Divoky V, Prchal JT. " Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. " Blood. 2005 Feb 1; 105 (3) : 1337-42.
Pubmed PMID: 15459009.
Mims MP, Hayes TG, Zheng S, Leal SM, Frolov A, Ittmann MM, Wheeler TM, Prchal JT. " Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. " Cancer Res.. 2006 Feb 1; 66 (3) : 1880; author re.
Pubmed PMID: 16452251.
Niu J, Mims MP. " Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review. " J. Clin. Oncol.. 2012 Nov 1; 30 (31) : e312-4.
Pubmed PMID: 22987080.
Aruch DB, Mims MP. " Paraneoplastic nephrotic syndrome and inflammatory arthritis at diagnosis in hodgkin lymphoma. " Clin Lymphoma Myeloma Leuk. 2013 Feb ; 13 (1) : 77-9.
Pubmed PMID: 23103086.
Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D. " Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. " Clin. Cancer Res.. 2006 Aug 15; 12 (16) : 4872-5.
Pubmed PMID: 16914574.
Advani AS, Gundacker HM, Sala-Torra O, Radich JP, Lai R, Slovak ML, Lancet JE, Coutre SE, Stuart RK, Mims MP, Stiff PJ, Appelbaum FR. " Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia. " Br. J. Haematol.. 2010 Dec ; 151 (5) : 430-4.
Pubmed PMID: 21113977.